Try GOLD - Free
RFK Jr. Discussed Limiting FDA Head’s Role After Complaints
The Wall Street Journal
|November 17, 2025
Trump administration officials including Health Secretary Robert F. Kennedy Jr. have discussed scaling back the role of Marty Makary, the Food and Drug Administration commissioner, according to people familiar with the matter.
FDA's Marty Makary
This story is from the November 17, 2025 edition of The Wall Street Journal.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
Listen
Translate
-
+
Change font size

